相似文献
1
Novel Azaindazole Derivatives as HCN2 Modulators for Treating Central Nervous System and Psychiatric Disorders, Namely, Schizophrenia, Autism, and Mood Disorders.新型氮杂吲哚衍生物作为HCN2调节剂用于治疗中枢神经系统和精神疾病，即精神分裂症、自闭症和情绪障碍。
ACS Med Chem Lett. 2025 May 9;16(6):927-928. doi: 10.1021/acsmedchemlett.5c00228. eCollection 2025 Jun 12.
2
Novel Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders.新型吲哚衍生物作为用于治疗精神病、精神疾病和中枢神经系统疾病的血清素能致幻剂。
ACS Med Chem Lett. 2025 May 30;16(6):982-983. doi: 10.1021/acsmedchemlett.5c00309. eCollection 2025 Jun 12.
3
Novel Indoline Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness and CNS Disorders.新型吲哚啉衍生物作为用于治疗精神病、精神疾病和中枢神经系统疾病的血清素能致幻剂。
ACS Med Chem Lett. 2025 Jan 23;16(2):196-197. doi: 10.1021/acsmedchemlett.5c00004. eCollection 2025 Feb 13.
4
Novel Compounds as 5-HT2A Receptor Modulators for Treating Psychiatric and Neurological Disorders.作为用于治疗精神和神经疾病的5-HT2A受体调节剂的新型化合物。
ACS Med Chem Lett. 2025 Mar 13;16(4):508-509. doi: 10.1021/acsmedchemlett.5c00093. eCollection 2025 Apr 10.
5
Novel Imidazotriazine Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune Disorders.新型咪唑并三嗪衍生物作为治疗炎症和自身免疫性疾病的白细胞介素-17调节剂
ACS Med Chem Lett. 2024 Dec 10;16(1):12-13. doi: 10.1021/acsmedchemlett.4c00573. eCollection 2025 Jan 9.
6
Novel Ergoline Compounds as 5-HT2A Agonists for Treating Mood Disorders Such as Depressive Disorders and Bipolar Disorders.新型麦角灵化合物作为5-HT2A激动剂用于治疗情绪障碍，如抑郁症和双相情感障碍。
ACS Med Chem Lett. 2024 Dec 20;16(1):32-33. doi: 10.1021/acsmedchemlett.4c00593. eCollection 2025 Jan 9.
7
Novel Tryptamine Compounds as 5-HT2A Agonists for Treating Mood Disorders such as Depressive Disorders and Bipolar Disorders.新型色胺化合物作为5-HT2A激动剂用于治疗情绪障碍，如抑郁症和双相情感障碍。
ACS Med Chem Lett. 2025 Feb 13;16(3):373-374. doi: 10.1021/acsmedchemlett.5c00047. eCollection 2025 Mar 13.
8
Novel 3-Cycloaminoindole Compounds as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders.新型3-环氨基吲哚化合物作为用于治疗精神病、精神疾病和中枢神经系统疾病的5-羟色胺能致幻剂。
ACS Med Chem Lett. 2025 Jan 4;16(2):190-191. doi: 10.1021/acsmedchemlett.4c00615. eCollection 2025 Feb 13.
9
Novel Indole and Pyrrolopyridine Derivatives as GPR17 Modulators for Treating Multiple Sclerosis.作为用于治疗多发性硬化症的GPR17调节剂的新型吲哚和吡咯并吡啶衍生物
ACS Med Chem Lett. 2025 Apr 9;16(5):736-737. doi: 10.1021/acsmedchemlett.5c00176. eCollection 2025 May 8.
10
Novel Pyridine Derivatives as 5-HT2A Agonists for Treating Psychiatric Disorders.新型吡啶衍生物作为治疗精神疾病的5-HT2A激动剂
ACS Med Chem Lett. 2025 Jan 8;16(2):192-193. doi: 10.1021/acsmedchemlett.4c00629. eCollection 2025 Feb 13.
本文引用的文献
1
GABA Receptor: Structure, Biological Functions, and Therapy for Diseases.γ-氨基丁酸受体：结构、生物学功能及疾病治疗
MedComm (2020). 2025 Apr 16;6(5):e70163. doi: 10.1002/mco2.70163. eCollection 2025 May.
2
Histamine Modulation of the Basal Ganglia Circuitry in the Motor Symptoms of Parkinson's Disease.组胺对帕金森病运动症状中基底神经节回路的调节作用
CNS Neurosci Ther. 2025 Feb;31(2):e70308. doi: 10.1111/cns.70308.
3
How do HCN channels play a part in Alzheimer's and Parkinson's disease?HCN 通道如何在阿尔茨海默病和帕金森病中发挥作用？
Ageing Res Rev. 2024 Sep;100:102436. doi: 10.1016/j.arr.2024.102436. Epub 2024 Jul 22.
4
Painful diabetic neuropathy: The role of ion channels.痛性糖尿病周围神经病变：离子通道的作用。
Biomed Pharmacother. 2024 Apr;173:116417. doi: 10.1016/j.biopha.2024.116417. Epub 2024 Mar 14.
5
Role of HCN channels in the functions of basal ganglia and Parkinson's disease.HCN 通道在基底神经节功能和帕金森病中的作用。
Cell Mol Life Sci. 2024 Mar 13;81(1):135. doi: 10.1007/s00018-024-05163-w.
Zotero 插件